64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate Cancer
Public ClinicalTrials.gov record NCT06970847. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The aim for this study is to investigate the ability of 64Cu-SAR-bisPSMA PET/CT to detect recurrence of prostate cancer
Study identification
- NCT ID
- NCT06970847
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 220 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 16, 2025 (Actual)
- Primary completion
- Dec 31, 2026 (Estimated)
- Completion
- Dec 31, 2026 (Estimated)
- Last update posted
- May 14, 2026
2025 – 2026
United States locations
- U.S. sites
- 18
- U.S. states
- 14
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UC Irvine | Irvine | California | 92697 | — |
| Comprehensive Urology Medical Group | Los Angeles | California | 90048 | — |
| Alarcon Urology Center | Montebello | California | 90640 | — |
| Biogenix Molecular | Miami | Florida | 33165 | — |
| Endeavor Health- Glenbrook Hospital | Glenview | Illinois | 60201 | — |
| Indiana University Health-IU Simon Cancer Center | Indianapolis | Indiana | 46202 | — |
| XCancer Research Network / LCMC Health EJGH | Metairie | Louisiana | 700006 | — |
| M. Health Fairview University of Minnesota Medical Center | Minneapolis | Minnesota | 55455 | — |
| St. Louis University | St Louis | Missouri | 63103 | — |
| XCancer | Omaha | Nebraska | 68130 | — |
| Albany Medical College | Albany | New York | 12208 | — |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15260 | — |
| Carolina Urologic Research Center | Myrtle Beach | South Carolina | 29572 | — |
| Urology Associates, P.C. | Nashville | Tennessee | 37209 | — |
| Urology Clinics of North Texas | Dallas | Texas | 75231 | — |
| The Urology Place | San Antonio | Texas | 78240 | — |
| Summit Urology | Murray | Utah | 84107 | — |
| Intermountain Medical Center | Salt Lake City | Utah | 84111 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06970847, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 14, 2026 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06970847 live on ClinicalTrials.gov.